Trilaciclib hydrochloride
CAS: 1977495-97-8
Ref. 3D-CED49597
| 1mg | 435,00 € | ||
| 2mg | 602,00 € | ||
| 5mg | 1.024,00 € | ||
| 10mg | 1.234,00 € | ||
| 25mg | 1.851,00 € |
Informação sobre produto
Trilaciclib is a small molecule that inhibits the CDK4/6 complex and is an inhibitor of cell proliferation. It has been shown to inhibit cancer growth in vitro, in vivo, and in humans. Trilaciclib is currently being tested as a treatment for hormone-dependent breast cancer. The drug works by targeting the microenvironment and inhibiting fibroblast growth factor (FGF) from binding to its receptor on the surface of cells. This leads to cell death through apoptosis and immunogenic cell death, which can be used for the treatment of tumors. Trilaciclib also enhances natural killer cell activity, which may help with cancer patients’ immunity against tumor cells.
Propriedades químicas
Consulta técnica sobre: 3D-CED49597 Trilaciclib hydrochloride
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
